Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: First evidence for genetic predisposition

Journal of Clinical Oncology

Volumn 29, Issue 12, 2011, Pages 1643-1649

  Szczepański, Tomasz ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Van Der Velden, Vincent H J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Waanders, Esmé ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Kuiper, Roland P ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Van Vlierberghe, Pieter ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Gruhn, Bernd ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Eckert, Cornelia ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Panzer Grümayer, Renate ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Basso, Giuseppe ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Cavé, Hélène ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Stadt, Udo Zur ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Campana, Dario ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Schrauder, André ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Sutton, Rosemary ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Van Wering, Elisabeth ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Meijerink, Jules P P ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n}   Van Dongen, Jacques J M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^g HUMBOLDT UNIVERSITY   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^k UNIVERSITY OF PADOVA   (Italy)

^l HÔPITAL ROBERT DEBRÉ   (France)

^m ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

ⁿ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^o ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC PREDISPOSITION; GENOME; HOMOZYGOSITY; HUMAN; LEUKEMIA RELAPSE; MALE; NOTCH1 GENE; PRIORITY JOURNAL; RECEPTOR GENE; SIL TAL1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REARRANGEMENT, T-LYMPHOCYTE; GENES, T-CELL RECEPTOR; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; MUTATION; NEOPLASMS, SECOND PRIMARY; NEW SOUTH WALES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTOR, NOTCH1; RECURRENCE; TENNESSEE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955043828     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.2877     Document Type: Article

References (41)

1. Jeha S, Pui CH: Risk-adapted treatment of pediatric acute lymphoblastic leukemia. Hematol Oncol Clin North Am 23:973-990, 2009
2. Pieters R, Carroll WL: Biology and treatment of acute lymphoblastic leukemia. Hematol Oncol Clin North Am 24:1-18, 2010
3. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009
4. Möricke A, Reiter A, Zimmermann M, et al: Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 111:4477-4489, 2008
5. Einsiedel HG, von Stackelberg A, Hartmann R, et al: Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: Results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt- Münster Group 87. J Clin Oncol 23:7942-7950, 2005 (Pubitemid 46657394)
6. Nguyen K, Devidas M, Cheng SC, et al: Factors influencing survival after relapse from acute lymphoblastic leukemia: A Children's Oncology Group study. Leukemia 22:2142-2150, 2008
7. Szczepański T, van der Velden VH, Raff T, et al: Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia 17:2149-2156, 2003 (Pubitemid 37428380)
8. Bene MC, Castoldi G, Knapp W, et al: Proposals for the immunological classification of acute leukemias: European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783-1786, 1995
9. Szczepański T, van der Velden VH, van Dongen JJ: Flow-cytometric immunophenotyping of normal and malignant lymphocytes. Clin Chem Lab Med 44:775-796, 2006
10. Verhagen OJ, Wijkhuijs AJ, van der Sluijs- Gelling AJ, et al: Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques. Leukemia 13:1298-1299, 1999 (Pubitemid 29396597)
11. Langerak AW, Szczepański T, van der Burg M, et al: Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 11:2192-2199, 1997 (Pubitemid 28043709)
12. van Dongen JJ, Langerak AW, Brüggemann M, et al: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257-2317, 2003 (Pubitemid 38072572)
13. Pongers-Willemse MJ, Seriu T, Stolz F, et al: Primers and protocols for standardized minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 Concerted Action-Investigation of minimal residual disease in acute leukemia. Leukemia 13:110-118, 1999 (Pubitemid 29043725)
14. Szczepański T, Pongers-Willemse MJ, Langerak AW, et al: Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood 93:4079-4085, 1999 (Pubitemid 29279249)
15. Breit S, Stanulla M, Flohr T, et al: Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 108:1151-1157, 2006 (Pubitemid 44232009)
16. Van Vlierberghe P, Pieters R, Beverloo HB, et al: Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol 143:153-168, 2008
17. Van Vlierberghe P, van Grotel M, Beverloo HB, et al: The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 108:3520-3529, 2006
18. Kuiper RP, Schoenmakers EF, van Reijmersdal SV, et al: High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 21:1258-1266, 2007 (Pubitemid 46831815)
19. Langemeijer SM, Kuiper RP, Berends M, et al: Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat Genet 41:838-842, 2009
20. Redon R, Ishikawa S, Fitch KR, et al: Global variation in copy number in the human genome. Nature 444:444-454, 2006 (Pubitemid 44809057)
21. van der Velden VH, Cazzaniga G, Schrauder A, et al: Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604-611, 2007 (Pubitemid 46444541)
22. Mullighan CG, Goorha S, Radtke I, et al: Genomewide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446:758-764, 2007 (Pubitemid 46582031)
23. Szczepański T, Willemse MJ, Brinkhof B, et al: Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. Blood 99:2315-2323, 2002 (Pubitemid 34525415)
24. Germano G, del Giudice L, Palatron S, et al: Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses: Consequences on minimal residual disease monitoring. Leukemia 17:1573-1582, 2003 (Pubitemid 36986960)
25. Li A, Zhou J, Zuckerman D, et al: Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: Implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection. Blood 102:4520-4526, 2003 (Pubitemid 37494119)
26. van Vlierberghe P, Meijerink JP, Lee C, et al: A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia. Leukemia 20:1245-1253, 2006 (Pubitemid 43905828)
27. Ford AM, Fasching K, Panzer-Grümayer ER, et al: Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood 98:558-564, 2001
28. Konrad M, Metzler M, Panzer S, et al: Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: Evidence for the persistence of a preleukemic clone. Blood 101:3635-3640, 2003 (Pubitemid 36857953)
29. Mullighan CG, Phillips LA, Su X, et al: Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322:1377-1380, 2008 (Pubitemid 352775249)
30. Zuna J, CavéH, Eckert C, et al: Childhood secondary ALL after ALL treatment. Leukemia 21:1431-1435, 2007 (Pubitemid 46965283)
31. Hunger SP, Sklar J, Link MP: Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: Report of three cases and review of the literature. J Clin Oncol 10:156-163, 1992
32. Szczepański T: Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? Leukemia 21:622-626, 2007 (Pubitemid 46444543)
33. Eguchi-Ishimae M, Eguchi M, Kempski H, et al: NOTCH1 mutation can be an early, prenatal genetic event in T-ALL. Blood 111:376-378, 2008
34. Fasching K, Panzer S, Haas OA, et al: Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. Blood 95:2722-2724, 2000 (Pubitemid 30210556)
35. Fischer S, Mann G, Konrad M, et al: Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin. Blood 110:3036-3038, 2007 (Pubitemid 350006958)
36. Grabher C, von Boehmer H, Look AT: Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6:347-359, 2006
37. Mansour MR, Duke V, Foroni L, et al: Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia. Clin Cancer Res 13:6964-6969, 2007 (Pubitemid 350276876)
38. Lo Nigro L, Cazzaniga G, Di Cataldo A, et al: Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis. Leukemia 13:190-195, 1999 (Pubitemid 29092651)
39. Bailey LC, Lange BJ, Rheingold SR, et al: Bonemarrow relapse in paediatric acute lymphoblastic leukaemia. Lancet Oncol 9:873-883, 2008
40. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al: Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41:1006-1010, 2009
41. Trevinõ LR, Yang W, French D, et al: Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41:1001-1005, 2009